Search Within

Qing-Bai She

Formats
  1. Meeting Abstract (17)
  2. Journal Article (14)
Groups
  1. Department of Medicine (30)
  2. GSK Faculty (30)
  3. Solid Tumor Oncology Division (30)
  4. Sloan Kettering Institute Faculty (29)
  5. Breast Medicine Service (28)
  6. Molecular Pharmacology and Chemistry Program Faculty (28)

More Groups

People
  1. Neal Rosen (28)
  2. David Solit (20)
  3. Qing Ye (14)
  4. Kathryn O'reilly (5)
  5. Christine Pratilas (4)
  6. Jose Lobo (4)

More People

Years
  1. 2016 (1)
  2. 2012 (3)
  3. 2010 (6)
  4. 2009 (2)
  5. 2008 (4)
  6. 2007 (2)

More Years

Publications
  1. Cancer Research (15)
  2. Cancer Cell (3)
  3. Clinical Cancer Research (3)
  4. BMC Cancer (1)
  5. Cancer Biology and Therapy (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Association for Cancer Research (20)
  2. Cell Press (3)
  3. Nature Publishing Group (2)
  4. American Association for the Advancement of Science (1)
  5. Biomed Central Ltd (1)
  6. National Academy of Sciences (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combined inhibition of PI3K/AKT and MAPK signaling is required to inhibit translational initiation and to induce apoptosis in human tumors
    Meeting Abstract

    She, Q. B.; Ye, Q.; Solit, D.; Rosen, N.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • AKT and cancer-Is it all mTOR?
    Journal Article

    Rosen, N.; She, Q. B.
    Cancer Cell (2006)

    Fulltext@MSK | Save
  • mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
    Journal Article

    O'reilly, K. E.; Rojo, F.; She, Q. B.; Solit, D.; Mills, G. B.; Smith, D.; Lane, H.; Hofmann, F.; Hicklin, D. J.; Ludwig, D. L.; more...
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Combined inhibition of PI3 kinase and EGFR overcomes the intrinsic apoptosis resistance of PTEN-null cancer cells and suppresses their xenograft growth
    Meeting Abstract

    She, Q. B.; Solit, D.; Ye, Q.; O'reilly, K.; Rosen, N.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • The IGF-1 dependent feedback activation of AKT
    Meeting Abstract

    Oreilly, K. E.; She, Q. B.; Solit, D.; Lane, H.; Hofmann, F.; Hicklin, D. J.; Baselga, J.; Rosen, N.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Genetic and pharmacological inhibition of p13 kinase signaling in vivo sensitizes tumors to EGFR inhibitors and to taxol
    Meeting Abstract

    She, Q. B.; Ye, Q.; She, Y. H.; Solit, D.; Gibbons, J.; Rosen, N.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells
    Journal Article

    She, Qing Bai; Solit, David B.; Ye, Qing; O'reilly, Kathryn E; Lobo, Jose; Rosen, Neal
    Cancer Cell (2005)

    Fulltext@MSK | Save
  • Restoration of PTEN-expression in tumor cells causes them to depend on EGFR for suppression
    Meeting Abstract

    She, Q.; Moasser, M. M.; Ye, Q.; O'reilly, K.; Solit, D.; Rosen, N.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Response and resistance to gefitinib (ZD1839, Iressa) in HER overexpressing tumor cells is mediated through the PI3K/Akt pathway
    Meeting Abstract

    She, Q. B.; Solit, D.; Basso, A.; Rosen, N.; Moasser, M. M.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Cyclin D expression and G1 progression are dependent on MEK-MAP kinase activity in tumor cells with B-Raf mutation but not in breast cancer cells with wild type Ras
    Meeting Abstract

    Sawai, A.; Basso, A. D.; Solit, D. B.; She, Q. B.; Grbovic, O.; Pratilas, C.; Chapman, P.; Moasser, M. M.; Rosen, N.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save